Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer.
Saved in:
| Title: | Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. |
|---|---|
| Authors: | Zavvar TS; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria., Santo G; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria., Gruber L; Department of Radiology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Kronthaler A; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria., Hagenbuchner J; 3D Bioprinting Core Facility, Department of Child and Adolescence Health, Pediatrics I, Medical University of Innsbruck, 6020 Innsbruck, Austria., Skvortsova I; EXTRO-Lab, Department of Therapeutic Radiology and Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Tyrolean Cancer Research Institute (TKFI), 6020 Innsbruck, Austria., Piro I; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany., Steiger K; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany., Martinovic V; Department of Pulmonology, Hospital Natters, 6161 Natters, Austria., Minasch D; Department of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Löffler-Ragg J; Department of Pulmonology, Hospital Natters, 6161 Natters, Austria., di Santo G; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria., Virgolini IJ; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria., von Guggenberg E; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria. |
| Source: | Pharmaceutics [Pharmaceutics] 2026 Jan 22; Vol. 18 (1). Date of Electronic Publication: 2026 Jan 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41599245 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [<superscript>177</superscript>Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zavvar+TS%22">Zavvar TS</searchLink>; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Santo+G%22">Santo G</searchLink>; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Gruber+L%22">Gruber L</searchLink>; Department of Radiology, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Kronthaler+A%22">Kronthaler A</searchLink>; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Hagenbuchner+J%22">Hagenbuchner J</searchLink>; 3D Bioprinting Core Facility, Department of Child and Adolescence Health, Pediatrics I, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Skvortsova+I%22">Skvortsova I</searchLink>; EXTRO-Lab, Department of Therapeutic Radiology and Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Tyrolean Cancer Research Institute (TKFI), 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Piro+I%22">Piro I</searchLink>; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Steiger+K%22">Steiger K</searchLink>; Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Martinovic+V%22">Martinovic V</searchLink>; Department of Pulmonology, Hospital Natters, 6161 Natters, Austria.<br /><searchLink fieldCode="AU" term="%22Minasch+D%22">Minasch D</searchLink>; Department of Radiation Oncology, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Löffler-Ragg+J%22">Löffler-Ragg J</searchLink>; Department of Pulmonology, Hospital Natters, 6161 Natters, Austria.<br /><searchLink fieldCode="AU" term="%22di+Santo+G%22">di Santo G</searchLink>; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Virgolini+IJ%22">Virgolini IJ</searchLink>; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22von+Guggenberg+E%22">von Guggenberg E</searchLink>; Department of Nuclear Medicine, Medical University of Innsbruck, 6020 Innsbruck, Austria. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101534003%22">Pharmaceutics</searchLink> [Pharmaceutics] 2026 Jan 22; Vol. 18 (1). <i>Date of Electronic Publication: </i>2026 Jan 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101534003 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1999-4923 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219994923%22">19994923 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceutics <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41599245 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/pharmaceutics18010138 Languages: – Code: eng Text: English Titles: – TitleFull: Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zavvar TS – PersonEntity: Name: NameFull: Santo G – PersonEntity: Name: NameFull: Gruber L – PersonEntity: Name: NameFull: Kronthaler A – PersonEntity: Name: NameFull: Hagenbuchner J – PersonEntity: Name: NameFull: Skvortsova I – PersonEntity: Name: NameFull: Piro I – PersonEntity: Name: NameFull: Steiger K – PersonEntity: Name: NameFull: Martinovic V – PersonEntity: Name: NameFull: Minasch D – PersonEntity: Name: NameFull: Löffler-Ragg J – PersonEntity: Name: NameFull: di Santo G – PersonEntity: Name: NameFull: Virgolini IJ – PersonEntity: Name: NameFull: von Guggenberg E IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 01 Text: 2026 Jan 22 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 1999-4923 Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: Pharmaceutics Type: main |
| ResultId | 1 |